G V Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.00 M
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.17 Cr
- Revenue Growth 0.37%
- Profit Growth 7.15%
- Ebitda 23.99%
- Net Worth 9.83%
- Total Assets -0.72%
About G V Meditech
G V Meditech Private Limited (GVMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 September 2002 and has a history of 22 years and five months. Its registered office is in New Delhi, Delhi, India.
The Corporate was formerly known as G V Meditech Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹23.17 Cr.
Shashi Rai, Indu Singh, and Arun Singh serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110DL2002PTC116794
- Company No.
116794
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does G V Meditech Private Limited offer?
G V Meditech Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Medical Consultancy Services, Medical Treatment Services, Trauma Surgery, Medical Surgery & Treatment Centres, Diagnostic Imaging & Pathology Labs, Medical Test Services, Medical Equipment & Accessories, Emergency Medical Equipment, Infertility Treatment.
Who are the key members and board of directors at G V Meditech?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shashi Rai ![]() | Director | 03-Sep-2002 | Current |
Arun Singh ![]() | Director | 03-Sep-2002 | Current |
Indu Singh ![]() | Director | 03-Sep-2002 | Current |
Financial Performance of G V Meditech.
G V Meditech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.37% increase. The company also saw a slight improvement in profitability, with a 7.15% increase in profit. The company's net worth moved up by a moderate rise of 9.83%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of G V Meditech?
In 2023, G V Meditech had a promoter holding of 68.09% and a public holding of 31.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹23.17 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 17.34 Cr
- De Lage Landen Financial Services India Private Limited : 2.85 Cr
- India Infoline Finance Limited : 2.20 Cr
- Union Bank Of India : 0.61 Cr
- Punjab National Bank : 0.17 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
28 Dec 2021 | Others | ₹14.00 Cr | Open |
30 Apr 2014 | India Infoline Finance Limited | ₹4.00 M | Open |
26 Dec 2013 | De Lage Landen Financial Services India Private Limited | ₹2.85 Cr | Open |
31 Jul 2013 | India Infoline Finance Limited | ₹4.00 M | Open |
30 May 2013 | India Infoline Finance Limited | ₹1.40 Cr | Open |
How Many Employees Work at G V Meditech?
G V Meditech has a workforce of 69 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of G V Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G V Meditech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.